Literature DB >> 15830199

[Functional significance of adenosine receptors in the eye and their dysregulation in pseudoexfoliation syndrome].

U Schlötzer-Schrehardt1, M Zenkel, C Hofmann-Rummelt, F E Kruse, G O Naumann.   

Abstract

BACKGROUND: Adenosine regulates many physiologic processes, such as aqueous humor secretion and intraocular pressure, via activation of its receptors. We investigated the expression of the receptor isoforms in eyes with PEX syndrome, which is associated with anterior chamber hypoxia and elevated intraocular pressure.
MATERIALS AND METHODS: The mRNA and protein expression of the adenosine receptor subtypes in anterior segment tissues of patients with PEX syndrome, glaucomas, and normal control eyes were analyzed comparatively.
RESULTS: Whereas the receptor subtypes A1, A2a, and A2b displayed no differential expression between PEX and control tissues, expression of the A3 adenosine receptor was consistently enhanced in the nonpigmented ciliary epithelium of all PEX eyes, independent of the presence of glaucoma, compared to normal and glaucomatous control eyes.
CONCLUSION: Considering the known role of the A3 adenosine receptor in modulating aqueous humor secretion, its selective upregulation in the ciliary epithelium may confer cytoprotection and be accessible to therapeutic intervention in PEX patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15830199     DOI: 10.1007/s00347-005-1216-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  29 in total

1.  A(1)-, A(2A)- and A(3)-subtype adenosine receptors modulate intraocular pressure in the mouse.

Authors:  M Y Avila; R A Stone; M M Civan
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport.

Authors:  J C Fleischhauer; C H Mitchell; W D Stamer; M O Karl; K Peterson-Yantorno; M M Civan
Journal:  J Membr Biol       Date:  2003-05-15       Impact factor: 1.843

3.  Structure-activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucoma.

Authors:  Takashi Okamura; Yasuhisa Kurogi; Kinji Hashimoto; Seiji Sato; Hiroshi Nishikawa; Kimio Kiryu; Yoshimitsu Nagao
Journal:  Bioorg Med Chem Lett       Date:  2004-07-16       Impact factor: 2.823

4.  The potential role of adenosine in regulating blood flow in the eye.

Authors:  S C Braunagel; J G Xiao; G C Chiou
Journal:  J Ocul Pharmacol       Date:  1988

5.  Effects of adenosine on ocular blood flow.

Authors:  M Portellos; C E Riva; S D Cranstoun; B L Petrig; A J Brucker
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-08       Impact factor: 4.799

Review 6.  Adenosine, oxidative stress and cytoprotection.

Authors:  V Ramkumar; D M Hallam; Z Nie
Journal:  Jpn J Pharmacol       Date:  2001-07

7.  8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome.

Authors:  G G Koliakos; A G P Konstas; U Schlötzer-Schrehardt; G Hollo; I E Katsimbris; N Georgiadis; R Ritch
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

8.  Knockout of A3 adenosine receptors reduces mouse intraocular pressure.

Authors:  Marcel Y Avila; Richard A Stone; Mortimer M Civan
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

9.  Adenosine receptor activation modulates intraocular pressure in rabbits.

Authors:  C E Crosson
Journal:  J Pharmacol Exp Ther       Date:  1995-04       Impact factor: 4.030

10.  Intraocular adenosine levels in normal and ocular-hypertensive patients.

Authors:  Bradley S Daines; Alexander R Kent; Melissa S McAleer; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2003-04       Impact factor: 2.671

View more
  2 in total

Review 1.  Potential for developing purinergic drugs for gastrointestinal diseases.

Authors:  Fernando Ochoa-Cortes; Andromeda Liñán-Rico; Kenneth A Jacobson; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

2.  Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.

Authors:  Hillevi Blomster; Tuomo Puustjärvi; Matti Kontkanen; Pirjo Valtonen; Markku Teräsvirta; Hannu Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.